REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)
CUSIP: 75886F107
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 103,945,862
- Total 13F shares
- 89,158,411
- Share change
- +2,084,438
- Total reported value
- $68,829,658,168
- Put/Call ratio
- 57%
- Price per share
- $771.87
- Number of holders
- 1,369
- Value change
- +$1,925,426,041
- Number of buys
- 685
- Number of sells
- 563
Quarterly Holders Quick Answers
What is CUSIP 75886F107?
CUSIP 75886F107 identifies REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75886F107:
Top shareholders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
8.7%
|
9,048,269
|
$5,087,570,211 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
8.5%
|
8,837,174
|
$4,968,878,140 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13D/G
13F
|
Company |
4.4%
|
4,742,611
|
$2,729,989,170 | -$462,704,633 | 30 May 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.5%
|
4,691,223
|
$2,637,733,956 | — | 30 Sep 2025 | |
| DODGE & COX |
13F
|
Company |
4.4%
|
4,550,845
|
$2,558,803,618 | — | 30 Sep 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
3.2%
|
3,359,563
|
$1,880,548,739 | -$2,703,197,470 | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,535,898
|
$1,419,627,369 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.4%
|
2,453,143
|
$1,379,328,713 | — | 30 Sep 2025 | |
| Capital World Investors |
13F
|
Company |
1.9%
|
1,998,366
|
$1,123,608,855 | — | 30 Sep 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.9%
|
1,979,453
|
$1,112,987,056 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.4%
|
1,484,473
|
$834,674,573 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
1,450,972
|
$815,840,196 | — | 30 Sep 2025 | |
| George D. Yancopoulos |
3/4/5
|
Bd. Co-Chair, President & CSO, Director |
—
mixed-class rows
|
1,721,022
mixed-class rows
|
$804,491,660 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.1%
|
1,175,277
|
$660,822,999 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
1,153,933
|
$648,821,756 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.95%
|
984,792
|
$553,718,997 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.92%
|
952,839
|
$535,752,949 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.89%
|
926,200
|
$520,774,474 | — | 30 Sep 2025 | |
| Leonard S. Schleifer |
3/4/5
|
Bd. Co-Chair, President & CEO, Director |
—
mixed-class rows
|
1,283,058
mixed-class rows
|
$493,538,603 | — | 31 Dec 2025 | |
| Capital International Investors |
13F
|
Company |
0.84%
|
876,564
|
$492,851,584 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.83%
|
861,593
|
$484,447,896 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.77%
|
804,910
|
$452,578,000 | — | 30 Sep 2025 | |
| VAGELOS P ROY |
3/4/5
|
Director |
—
class O/S missing
|
467,104
|
$444,337,350 | — | 03 Apr 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.74%
|
770,359
|
$433,149,757 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
755,565
|
$424,831,533 | — | 30 Sep 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.72%
|
744,173
|
$418,426,152 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.69%
|
721,354
|
$405,595,821 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.67%
|
696,681
|
$391,722,827 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.65%
|
671,630
|
$377,637,607 | — | 30 Sep 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.64%
|
660,595
|
$371,435,512 | — | 30 Sep 2025 | |
| Amundi |
13F
|
Individual |
0.6%
|
621,741
|
$364,016,919 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.56%
|
584,505
|
$328,594,000 | — | 30 Sep 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.53%
|
548,734
|
$308,536,666 | — | 30 Sep 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.5%
|
523,883
|
$294,563,694 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.48%
|
499,096
|
$280,615,836 | — | 30 Sep 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.46%
|
477,810
|
$268,658,229 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.46%
|
477,652
|
$268,569,390 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.45%
|
469,903
|
$264,212,360 | — | 30 Sep 2025 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Individual |
0.44%
|
462,502
|
$260,051,010 | — | 30 Sep 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.43%
|
445,325
|
$250,392,888 | — | 30 Sep 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.4%
|
415,714
|
$233,743,278 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.37%
|
386,884
|
$217,533,266 | — | 30 Sep 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.37%
|
381,015
|
$214,232,754 | — | 30 Sep 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.36%
|
374,264
|
$210,437,419 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.36%
|
373,095
|
$209,780,000 | — | 30 Sep 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.36%
|
369,965
|
$208,479,691 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.33%
|
339,489
|
$190,884,479 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.31%
|
325,921
|
$183,255,598 | — | 30 Sep 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.31%
|
323,370
|
$181,676,120 | — | 30 Sep 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.3%
|
307,289
|
$172,779,386 | — | 30 Sep 2025 |
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) as of Q4 2025
As of 31 Dec 2025,
REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) was held by
1,369 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,158,411 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, Dodge & Cox, JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, Nuveen, LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
1,370
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1,235
Q4 2025 holders
1,369
Holder diff
134
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.